Item 2.02. Results of Operations and Financial Condition.
On January 27, 2023, HCA Healthcare, Inc. (the "Company") issued a press release
announcing, among other matters, its results of operations for the fourth
quarter and year ended December 31, 2022, the text of which is set forth as
Exhibit 99.1.
Item 7.01. Regulation FD Disclosure.
On January 27, 2023, the Company issued a press release announcing, among other
matters, its results of operations for the fourth quarter and year ended
December 31, 2022, the text of which is set forth as Exhibit 99.1.
Item 8.01. Other Events.
On January 27, 2023, the Company announced that its Board of Directors had
authorized an additional share repurchase program for up to $3 billion of the
Company's outstanding common stock. Repurchases will be made in accordance with
applicable securities laws from time to time in the open market, through
privately negotiated transactions, or otherwise.
On January 27, 2023, the Company also announced that its Board of Directors had
declared a quarterly cash dividend of $0.60 per share of the Company's common
stock. The dividend will be paid on March 31, 2023 to stockholders of record at
the close of business on March 17, 2023.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
Exhibit 99.1 Press Release, dated January 27, 2023
Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses